Research Grants
Program Guidance and
Application
FAQ
Contact
|
|
 |
Research Grants Program Guidance
Lantheus Medical Imaging’s Investigator Sponsored Trial (IST) program is designed to facilitate investigator–sponsored research that explores important scientific and clinical questions related to Lantheus products.
Lantheus defines ISTs as unsolicited clinical, pre-clinical, retrospective or health economic and outcomes research study proposals involving a marketed Lantheus product. The Investigator serves as the Sponsor of the study and if approved by the Research Review Committee, Lantheus will provide support for the research with study drug and/or funding.
The program is open to all academic and community-based physicians and researchers who are interested in conducting their own research.
The Research Review Committee is dedicated to providing thorough and fair review of every application submitted. Applications are assessed for significance, approach, innovation, clinical relevance and environment.
The investigator must comply with all applicable federal, state and local regulations related to conducting research (FDA-Code of Federal Regulations, Office Inspector General, Department of Health and Human Services, Food, Drug and Cosmetic Act) including but not limited to:
- Securing approval by an Institutional or independent IRB, Ethics Committee or IACUC.
- If deemed necessary, submitting the protocol to the FDA for an IND number.
- Posting the study on www.clinicaltrials.gov
The Principle Investigator is responsible for all aspects of study conduct including oversight of all study personnel, administration and dispensing of study drug, maintenance of drug accountability, research records and reporting of adverse events. Additional information is located on Page 2 of the research grant application form.
Research Grant Application Form |
